Reaction of copper(II) acetate with 1,1′-[(2,2-dimethylpropane-1,3-diyl)bis(nitrilomethylidyne)]-di-2-naphthol (H2L) gave the diphenoxido-bridged binuclear copper(II) complex [Cu2L2]. Its crystal structure shows a slightly distorted square pyramidal geometry around both of the copper(II) ions. In the symmetric Cu2O2 core, each of the phenoxido bridges occupies an equatorial position around one of the copper(II) centres. A broken symmetry (BS) computation based on density functional theory (DFT) evaluated the magnetic interaction in the complex using the (U)B3LYP level of theory in association with the basis sets LANL2DZ for the copper atoms and 6-31G** for the other atoms. The calculations showed ferromagnetic interaction between the two magnetic copper(II) centres with a magnetic coupling constant (J) of 1.16 cm−1.
The title Schiff base compound {systematic name: 2-[5-[(E)-(2-hydroxybenzylidene)amino]-4-(2-{5-[(E)-(2-hydroxybenzylidene)amino]-2-(2-hydroxyphenyl)-1,3-thiazol-4-yl}disulfanyl)-1,3-thiazol-2-yl]phenol}, CHNOS, incorporating a disulfanediyl (dithio) linkage, was obtained from the condensation reaction between two equivalents of salicylaldehyde and one equivalent of dithiooxamide in dimethylformamide, and was characterized by elemental analysis, IR spectroscopic analysis and single-crystal X-ray diffraction. A one-dimensional chain is formed along the b axis via double intermolecular C-H...S hydrogen bonds. The HOMO (highest occupied molecular orbital) and LUMO (lowest unoccupied molecular orbital) energies and some related molecular parameters were calculated at the B3LYP/6-311G(d,p) level of theory. The molecular hyperpolarizability was also calculated.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.